Literature DB >> 25851994

MiR-107 down-regulates SIAH1 expression in human breast cancer cells and silencing of miR-107 inhibits tumor growth in a nude mouse model of triple-negative breast cancer.

Li Zhang1, Ping Ma2, Li-Mei Sun1, Yan-Chun Han1, Bai-Lin Li3, Xiao-Yi Mi1, En-Hua Wang1, Min Song1.   

Abstract

We have reported that SIAH1 is down-regulated and associated with apoptosis and invasion in human breast cancer. However, the molecular mechanisms leading to SIAH1 down-regulation remain to be elucidated. Here, we demonstrated that miR-107 directly down-regulates SIAH1 expression in human breast cancer cells. Over- expression of miR-107 reduced SIAH1 expression, promoted human breast cancer cell proliferation, colony formation, migration and invasion, and inhibited apoptosis. On the contrary, silencing of miR-107 increased SIAH1 expression and inhibited the tumor growth of MDA-MB-231 cells, a kind of triple-negative breast cancer (TNBC) cells, in vitro and in vivo. Our results reveal that miR-107 is an upstream regulator for SIAH1 down-regulation in human breast cancer cells and miR-107 provides a potential effective target for the treatment of TNBC.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  SIAH1; breast cancer; miR-107; miRNAs; triple-negative breast cancer

Mesh:

Substances:

Year:  2015        PMID: 25851994     DOI: 10.1002/mc.22320

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  15 in total

1.  Long non-coding RNA ZEB2-AS1 regulates osteosarcoma progression by acting as a molecular sponge of miR-107 to modulate SALL4 expression.

Authors:  Yu Wang; Ning Liu; Ming-Yue Li; Mao-Fang Du
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

2.  Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection.

Authors:  Marc Hirschfeld; Gerta Rücker; Daniela Weiß; Kai Berner; Andrea Ritter; Markus Jäger; Thalia Erbes
Journal:  Mol Diagn Ther       Date:  2020-04       Impact factor: 4.074

3.  Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/β-catenin axis.

Authors:  Jing Yao; Zhe Yang; Jun Yang; Zhi-Gang Wang; Zheng-Yun Zhang
Journal:  Aging (Albany NY)       Date:  2021-05-23       Impact factor: 5.682

4.  MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer.

Authors:  Huan Xia; Yang Li; Xiaohong Lv
Journal:  Int J Oncol       Date:  2016-07-25       Impact factor: 5.650

5.  In vitro effect of microRNA-107 targeting Dkk-1 by regulation of Wnt/β-catenin signaling pathway in osteosarcoma.

Authors:  Zhi-Cai Zhang; Jian-Xiang Liu; Zeng-Wu Shao; Fei-Fei Pu; Bai-Chuan Wang; Qiang Wu; Yu-Kun Zhang; Xian-Lin Zeng; Xiao-Dong Guo; Shu-Hua Yang; Tong-Chuan He
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

6.  MiR-107 function as a tumor suppressor gene in colorectal cancer by targeting transferrin receptor 1.

Authors:  Yuxiang Fu; Liewen Lin; Ligang Xia
Journal:  Cell Mol Biol Lett       Date:  2019-05-16       Impact factor: 5.787

7.  Mechanism of miR-107-targeting of regulator of G-protein signaling 4 in hepatocellular carcinoma.

Authors:  Di Xiao; Hai-Xia Gao
Journal:  Oncol Lett       Date:  2019-09-12       Impact factor: 2.967

8.  Effects of MiR-107 on The Chemo-drug Sensitivity of Breast Cancer Cells.

Authors:  Yong Luo; Tebo Hua; Xia You; Jinfeng Lou; Xuxiong Yang; Ningwen Tang
Journal:  Open Med (Wars)       Date:  2019-07-09

9.  SIAH ubiquitin ligases regulate breast cancer cell migration and invasion independent of the oxygen status.

Authors:  M Gordian Adam; Sonja Matt; Sven Christian; Holger Hess-Stumpp; Andrea Haegebarth; Thomas G Hofmann; Carolyn Algire
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

10.  Suppression of cell migration is promoted by miR-944 through targeting of SIAH1 and PTP4A1 in breast cancer cells.

Authors:  Ali Flores-Pérez; Laurence A Marchat; Sergio Rodríguez-Cuevas; Verónica Piña Bautista; Lizeth Fuentes-Mera; Diana Romero-Zamora; Anabel Maciel-Dominguez; Olga Hernández de la Cruz; Miguel Fonseca-Sánchez; Erika Ruíz-García; Horacio Astudillo-de la Vega; César López-Camarillo
Journal:  BMC Cancer       Date:  2016-07-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.